Protocol T05018-2004: A Phase 2, randomized, open-label (with blinded plasminogen activator and placebo control groups) study to evaluate the effects of different intra-thrombus infusion regimens of plasmin compared to plasminogen activator and placebo in patients with acute lower extremity native artery or bypass graft occlusion.